Ambri gets new business software
Wednesday, 01 May, 2002
Ambri has adopted new business software and services from Frontstep, to help it to take its new clinical diagnostic system from prototype to full-scale manufacture.
Ambri's CEO and managing director, Joe Shaw, said Frontstep's solution will provide a flexible and highly scalable platform for the company as it moves closer toward establishing commercial manufacturing operations and its North American expansion.
Frontsteps' SyteLine provides a business management platform that will allow Ambri to satisfy the US Food and Drug Administration regulations.
"We will not become a global organisation without people and suppliers who are dedicated to joining with us to achieve this objective," said Shaw.
Birth by C-section increases odds of measles vaccine failure
A single dose of the measles vaccine is up to 2.6 times more likely to be completely ineffective...
Low stress resilience may increase psoriasis risk
Young adults who find it harder to cope with stress are more likely to develop psoriasis later in...
Nano carrier could enable oral insulin for diabetics
A new form of oral insulin utilises a nanoscale material that surrounds individual insulin...